Labriola-Tompkins E, Chandran C, Kaffka K L, Biondi D, Graves B J, Hatada M, Madison V S, Karas J, Kilian P L, Ju G
Department of Molecular Genetics, Hoffmann-La Roche Inc., Nutley, NJ 07110.
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11182-6. doi: 10.1073/pnas.88.24.11182.
Human interleukin 1 beta (IL-1 beta) exerts its diverse biological effects by binding to specific receptors on target cells. Two types of IL-1 receptor (IL-1R) have been identified: the type I IL-1R (p80) and the type II IL-1R (p68). Using site-specific mutagenesis, we have identified the binding site on IL-1 beta for the murine type I IL-1R. Analogs of the IL-1 beta protein containing defined amino acid substitutions were produced and tested for competitive binding to the two IL-1Rs. Substitutions of the amino acids at seven positions resulted in analogs that had greater than or equal to 100-fold reductions in competitive binding to the type I IL-1R, while maintaining substantial binding to the type II IL-1R. These seven amino acids (Arg-4, Leu-6, Phe-46, Ile-56, Lys-93, Lys-103, and Glu-105) are clustered in the IL-1 beta molecule, forming a discontinuous binding site. The side chains of all seven residues are exposed on the surface of IL-1 beta. The cumulative binding energies contributed by each of the residues predict a binding affinity that is consistent with the observed Kd of the wild-type protein for the type I IL-1R.
人白细胞介素1β(IL-1β)通过与靶细胞上的特异性受体结合发挥其多种生物学效应。已鉴定出两种类型的IL-1受体(IL-1R):I型IL-1R(p80)和II型IL-1R(p68)。利用位点特异性诱变,我们确定了小鼠I型IL-1R在IL-1β上的结合位点。制备了含有特定氨基酸取代的IL-1β蛋白类似物,并测试其与两种IL-1R的竞争性结合。七个位置的氨基酸取代产生的类似物与I型IL-1R的竞争性结合降低了100倍或更多,同时保持与II型IL-1R的大量结合。这七个氨基酸(Arg-4、Leu-6、Phe-46、Ile-56、Lys-93、Lys-103和Glu-105)聚集在IL-1β分子中,形成一个不连续的结合位点。所有七个残基的侧链都暴露在IL-1β的表面。每个残基贡献的累积结合能预测的结合亲和力与野生型蛋白对I型IL-1R观察到的Kd一致。